Teva Pharmaceutical (Israel) Investor Sentiment

TEVA Stock  ILA 5,977  64.00  1.06%   
About 61% of Teva Pharmaceutical's investor base is looking to short. The analysis of current outlook of investing in Teva Pharmaceutical Industries suggests that many traders are alarmed regarding Teva Pharmaceutical's prospects. The current market sentiment, together with Teva Pharmaceutical's historical and current headlines, can help investors time the market. In addition, many technical investors use Teva Pharmaceutical stock news signals to limit their universe of possible portfolio assets.
  
over three months ago at news.google.com         
Wellington Management Group LLP Cuts Holdings in Teva Pharmaceutical Industries Limited - MarketBeat
Google News at Macroaxis
over three months ago at news.google.com         
EU top court rejects Servier appeal against EU antitrust fine - Marketscreener.com
Google News at Macroaxis
over three months ago at news.google.com         
Range Financial Group LLC Buys Shares of 56,499 Teva Pharmaceutical Industries Limited - MarketBeat
Google News at Macroaxis
over three months ago at news.google.com         
Did Teva Pharmaceutical Industries Limited s Pivot to Growth Strategy Help It Get a Positive Rating ...
Google News at Macroaxis
over three months ago at news.google.com         
Teva pharmaceutical director Mignone sells shares worth 8.84 million By Investing.com - Investing.co...
Google News at Macroaxis
over three months ago at news.google.com         
Proactive Strategies - Stock Traders Daily
Google News at Macroaxis
over three months ago at news.google.com         
Burford Brothers Inc. Takes 1.46 Million Position in Teva Pharmaceutical Industries Limited - Market...
Google News at Macroaxis
over three months ago at news.google.com         
Teva Pharmaceutical Industries Reaches New 52-Week High at 17.54 - MarketBeat
Google News at Macroaxis
over three months ago at news.google.com         
CIBC Asset Management Inc Has 1.02 Million Stock Position in Teva Pharmaceutical Industries Limited ...
Google News at Macroaxis
over three months ago at news.google.com         
Teva Pharmaceutical Buy This Bargain Before Its Gone - Seeking Alpha
Google News at Macroaxis
over three months ago at news.google.com         
UBS Group AG Sells 429,968 Shares of Teva Pharmaceutical Industries Limited - MarketBeat
Google News at Macroaxis
over three months ago at news.google.com         
Teva Pharmaceutical Industries Limited Given Consensus Recommendation of Moderate Buy by ... - Marke...
Google News at Macroaxis
over six months ago at news.google.com         
Teva Pharmaceutical Industries Price Target Raised to 21.00 at Bank of America - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
Teva Pharmaceutical Industries NYSETEVA investor five-year losses grow to 55 percent as the stock sh...
Google News at Macroaxis
over six months ago at news.google.com         
Tevas Adderall back in stock - FiercePharma
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Teva Pharmaceutical that are available to investors today. That information is available publicly through Teva media outlets and privately through word of mouth or via Teva internal channels. However, regardless of the origin, that massive amount of Teva data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Teva Pharmaceutical news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Teva Pharmaceutical relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Teva Pharmaceutical's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Teva Pharmaceutical alpha.

Teva Pharmaceutical Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Teva Stock analysis

When running Teva Pharmaceutical's price analysis, check to measure Teva Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Teva Pharmaceutical is operating at the current time. Most of Teva Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Teva Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Teva Pharmaceutical's price. Additionally, you may evaluate how the addition of Teva Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm